To test whether endosomal trafficking is affected in DS, we examined transferrin (Tf) receptor and fibroblast growth factor (FGF) receptor 1 (FGFR1) trafficking, which follow two distinct fates upon internalization: recycling to the plasma membrane and targeting to lysosomes for degradation. Here, FGFR1 is linked to Dravet syndrome.